Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Dysplasia 1Squamous Intraepithelial Lesions 1Carcinoma, Basal Cell 1

Interventions

VGX-3100 2Cidofovir 2Biopsy 2Aminolevulinic Acid 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2epigallocatechin gallate 1Solutions 1Red Light 1Probiotics 1Polymerase Chain Reaction 1Megestrol Acetate 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Gene Expression Profiling 1Gels 1GPI0100 1Folic Acid 1Electroporation Therapies 1Electroporation 1DNA Methylation 1Chemoprevention 1Celecoxib 1Blue Light 1Biological Therapy 1Antigens 1Adjuvants, Pharmaceutic 1Acetic Acid 15-aminolaevulinic acid-n-pentylester 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Squamous Intraepithelial Lesions × Chemoprevention × Clear all
NCT00072540 2013-11-08

S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix

SWOG Cancer Research Network

Phase 2 Withdrawn
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡